Mineralys Therapeutics Inc. (NASDAQ:MLYS) is one of the 11 Best Day Trading Stocks to Buy Now. Biopharmaceutical company Mineralys Therapeutics Inc. (NASDAQ:MLYS) scored a win on March 9th when it ...

The FDA accepts the NDA for lorundrostat, a selective aldosterone synthase inhibitor, for adults with uncontrolled or resistant hypertension.

Delve into the field of pulmonary hypertension as GSK places a $950M bet on 35Pharma's candidate HS235 following the footsteps of Winrevair.

Three combination therapies for hypertension are equally effective in reducing blood pressure, according to a new global study conducted in India, where this significant health burden affects nearly ...

Scientists have identified a widely prescribed hypertension drug as a potential key to extending lifespan and slowing aging.

Lorundrostat led to significant reductions in systolic blood pressure and UACR in CKD patients. Adverse events were low, with 3% discontinuing during lorundrostat vs. 2% on placebo. A new wave of ...

The hypertension drug rilmenidine has been shown to slow down aging in worms, an effect that in humans could hypothetically help us live longer and keep us healthier in our latter years. Previous ...

Hypertension can affect your mind, heart, eyes and more, often without causing any obvious symptoms at all.

Picture this: A man in his 50s, previously fit and healthy, suddenly experienced left-sided numbness and unsteadiness. He didn’t smoke, drink alcohol or use illicit substances. When he arrived at the ...

The FDA reports that the affected capsules contain nitrosamine impurities, specifically called “N-Nitroso Prazosin impurity C” in the official report, that go beyond the safety limit set by the ...

A study in Delhi reveals that patients with treatment-resistant hypertension often lack understanding and adhere poorly to medication, impacting control.